As part of the Section on Neuroscience, Dr. Cesar V. Borlongan was elected as an AAAS Fellow for distinguished contributions to the field of stem cell therapy for neurological disorders, particularly for advancing translational biomedical research of cell based-therapeutics in stroke. He is also elected as an AIMBE Fellow. He currently holds the position of Distinguished Professor and Vice-Chairman for research in Neurosurgery and Brain Repair, and Director of the Center of Excellence for Aging and Brain Repair at the University of South Florida, and is a world leader in stem cell research for stroke therapy. His highly innovative translational "bench to clinic" research has led to 6 FDA-approved clinical trials of cell transplantation in stroke, including the world's first cell therapy in stroke patients. He previously was a tenured professor at the Medical College of Georgia. Trained for 5 years as an NIH Staff Fellow, he has received continuous multiple federal funding totaling over $20 million from the VA and NIH since 2002. He is an author of more than 440 peer-reviewed publications, lead editor of 2 books, and serves as editorial board member of many scientific journals, including Stroke, JCBFM, Stem Cells, Scientific Reports, Translational Stroke Research, Stem Cell Reviews and Reports, International Journal of Molecular Sciences, CNS Neuroscience & Therapeutics, PLoS ONE, CNS & Neurological Disorders - Drug Targets, and Brain Research. He has served as a regular study section member of NIH, including NOMD and NSD-A. He is a charter member of the National Academy of Inventors.